| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-12 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 9e-09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |